Your browser doesn't support javascript.
loading
Prolyl hydroxylation by EglN2 destabilizes FOXO3a by blocking its interaction with the USP9x deubiquitinase.
Zheng, Xingnan; Zhai, Bo; Koivunen, Peppi; Shin, Sandra J; Lu, Gang; Liu, Jiayun; Geisen, Christoph; Chakraborty, Abhishek A; Moslehi, Javid J; Smalley, David M; Wei, Xin; Chen, Xian; Chen, Zhengming; Beres, Justine M; Zhang, Jing; Tsao, Jen Lan; Brenner, Mitchell C; Zhang, Yuqing; Fan, Cheng; DePinho, Ronald A; Paik, Jihye; Gygi, Steven P; Kaelin, William G; Zhang, Qing.
Afiliação
  • Zheng X; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, USA;
  • Zhai B; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA;
  • Koivunen P; Biocenter Oulu, Faculty of Biochemistry and Molecular Medicine, Oulu Center for Cell-Matrix Research, University of Oulu, FIN-90014 Oulu, Finland;
  • Shin SJ; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York 10065, USA;
  • Lu G; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02215, USA;
  • Liu J; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02215, USA;
  • Geisen C; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02215, USA;
  • Chakraborty AA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02215, USA;
  • Moslehi JJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02215, USA;
  • Smalley DM; Department of Pharmacology, University of North Carolina, Chapel Hill, North Carolina 27599, USA;
  • Wei X; Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, North Carolina 27599, USA;
  • Chen X; Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, North Carolina 27599, USA;
  • Chen Z; Department of Public Health, Division of Biostatistics and Epidemiology, Weill Cornell Medical College, New York, New York 10065, USA;
  • Beres JM; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, USA;
  • Zhang J; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, USA;
  • Tsao JL; Fibrogen, Incorporated, San Francisco, California 94158, USA;
  • Brenner MC; Fibrogen, Incorporated, San Francisco, California 94158, USA;
  • Zhang Y; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York 10065, USA;
  • Fan C; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, USA;
  • DePinho RA; Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA;
  • Paik J; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York 10065, USA;
  • Gygi SP; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA;
  • Kaelin WG; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02215, USA; Howard Hughes Medical Institute, Chevy Chase, Maryland 20815, USA;
  • Zhang Q; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, USA; Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina 27599, USA.
Genes Dev ; 28(13): 1429-44, 2014 Jul 01.
Article em En | MEDLINE | ID: mdl-24990963
ABSTRACT
The three EglN prolyl hydroxylases (EglN1, EglN2, and EglN3) regulate the stability of the HIF transcription factor. We recently showed that loss of EglN2, however, also leads to down-regulation of Cyclin D1 and decreased cell proliferation in a HIF-independent manner. Here we report that EglN2 can hydroxylate FOXO3a on two specific prolyl residues in vitro and in vivo. Hydroxylation of these sites prevents the binding of USP9x deubiquitinase, thereby promoting the proteasomal degradation of FOXO3a. FOXO transcription factors can repress Cyclin D1 transcription. Failure to hydroxylate FOXO3a promotes its accumulation in cells, which in turn suppresses Cyclin D1 expression. These findings provide new insights into post-transcriptional control of FOXO3a and provide a new avenue for pharmacologically altering Cyclin D1 activity.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Regulação Neoplásica da Expressão Gênica / Ubiquitina Tiolesterase / Fatores de Transcrição Forkhead / Prolina Dioxigenases do Fator Induzível por Hipóxia Limite: Animals Idioma: En Revista: Genes Dev Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Regulação Neoplásica da Expressão Gênica / Ubiquitina Tiolesterase / Fatores de Transcrição Forkhead / Prolina Dioxigenases do Fator Induzível por Hipóxia Limite: Animals Idioma: En Revista: Genes Dev Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2014 Tipo de documento: Article